720MO IBI354 (anti-HER2 antibody-drug conjugate [ADC]) in patients (pts) with advanced gynecological cancers (Gynecol C): Results from a phase I study
Jian Shu(Fuzhou University), Qi Zhou(Fudan University), Rui An(The Eighth Hospital of Xi'an), Huaqiang Zhou(Sun Yat-sen University), L. Zhu(Nanjing Drum Tower Hospital), Xi Chen(Jilin Province Science and Technology Department), Zhiyong Zhang(Institute of Geology and Geophysics), Guoqiang Li(Southwest University of Science and Technology), Xiaolin Wang(University of Toronto), Qian Zhu(Panzhihua Central Hospital), Huiping Liu(Guangxi University), Xiaohong Xu(Zhejiang Cancer Hospital), Yunchao Huang(North China University of Water Resources and Electric Power), Jie Tang(Central South University), Ting Zhu(The First People's Hospital of Jiangxia District), Wen Cheng(Tongji University), Qinghua Xu(Anhui Academy of Medical Sciences), Hui Zhao, Jie Gao(Jiangxi Provincial Cancer Hospital), Ruixia Guo(Shanghai Ninth People's Hospital)
Cited by 6
Related Papers
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
|The Lancet Oncology|2015|1.6k
Recent Advances in Photoelectrochemical Sensing: From Engineered Photoactive Materials to Sensing Devices and Detection Modes
|Analytical Chemistry|2019|947
Clinical Findings in 111 Cases of Influenza A (H7N9) Virus Infection
|New England Journal of Medicine|2013|655
Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
|Journal of Clinical Oncology|2011|644